SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MedImmune
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bill small who wrote (104)3/12/1998 3:04:00 PM
From: Pseudo Biologist  Read Replies (1) of 416
 
Bill, do you care to comment on the post I made a day or two ago to Alex? That would be post #103 or
Message 3676975

Maybe you have more information on the "secondary" products, meaning the anti-CD2 antibodies and/or the vaccine project.

Also, what would you think a reasonable projection of Synagis annual sales would be? Goldman Sachs says about $400 mill, but I've seen larger numbers as well.

Thanks,

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News